Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 245
Healthy volunteers: no

Brief summary:
Efficacy and safety of BI 1356 compared to placebo in patients with type 2 diabetes who have insufficient glycaemic control despite treatment with a sulfonylurea drug.

Detailed description:

Arms:
arm 1: 5 mg orally (po) once daily arm 2: one tablet once daily

Interventions: intervention 1: BI 1356 intervention 2: Placebo
Intervention descriptions: intervention 1: 5mg orally (po) tablet qd intervention 2: Placebo matching BI 1356 5mg one tablet daily

Protocol document: